India embarks on vaccine-development scheme

Area of Science:

• Biotechnology
• Vaccinology
• Infectious Diseases

Background:

• India's vaccine development program targets six critical diseases: AIDS, cholera, Japanese encephalitis, malaria, rabies, and tuberculosis.
• The initiative is a collaborative effort involving 12 national research institutions and two private companies, Indian Immunologicals and Bharat Biotech.

Purpose of the Study:

• To outline India's comprehensive vaccine development program.
• To detail the specific diseases targeted and the entities involved in the research and development.

Main Methods:

• The Department of Biotechnology (DBT) oversees the project, coordinating research across multiple institutions.
• Development includes an oral recombinant cholera vaccine (Phase I trials completed), a DNA rabies vaccine (preclinical development), and an AIDS vaccine using a poxvirus construct (HIV-1 subtype C).

Main Results:

• Cholera and rabies vaccines are predicted for deployment by 2002.
• An oral recombinant cholera vaccine demonstrated safety in Phase I trials.
• A DNA rabies vaccine is in late preclinical development.
• An AIDS vaccine targeting HIV-1 subtype C is progressing towards animal studies.

Conclusions:

• India is making significant strides in vaccine development for major infectious diseases.
• The program showcases a coordinated national effort combining public and private sector expertise.
• Despite modest funding, the project aims for timely vaccine deployment, starting with cholera and rabies.